Evidence map›Paper›PMID 33980870›Full record

ArticleNPJ schizophrenia2021

Eye movements in patients in early psychosis with and without a history of cannabis use.

Musa Basseer Sami, Luciano Annibale, Aisling O'Neill, Tracy Collier, Chidimma Onyejiaka, Savitha Eranti, Debasis Das, Marlene Kelbrick, Philip McGuire, Steve C R Williams and 3 more

Open access · goldAbstract read
In one paragraph

Article in NPJ schizophrenia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 2 countries.

Musa Basseer SamiInstitute of Psychiatry, Psychology and Neurosciences King's College London, London, UK. musa.sami@nottingham.ac.uk.ORCID http://orcid.org/0000-0002-4420-8618
Luciano AnnibaleInstitute of Psychiatry, Psychology and Neurosciences King's College London, London, UK.
Aisling O'NeillInstitute of Psychiatry, Psychology and Neurosciences King's College London, London, UK.
Tracy CollierInstitute of Psychiatry, Psychology and Neurosciences King's College London, London, UK.
Chidimma OnyejiakaInstitute of Psychiatry, Psychology and Neurosciences King's College London, London, UK.
Savitha ErantiEast London Foundation Trust, London, UK.
Debasis DasLeicestershire Partnership NHS Trust, Leicester, UK.
Marlene KelbrickNorthamptonshire Healthcare NHS Foundation Trust, Kettering, UK.
Philip McGuireInstitute of Psychiatry, Psychology and Neurosciences King's College London, London, UK.
Steve C R WilliamsCentre for Neuroimaging Sciences, King's College London, London, UK.
Anas RanaCentre for Computational Biology, University of Birmingham, Birmingham, UK.
Ulrich EttingerDepartment of Psychology, University of Bonn, Bonn, Germany.
Sagnik BhattacharyyaInstitute of Psychiatry, Psychology and Neurosciences King's College London, London, UK.
King's College London · GBEast London NHS Foundation Trust · GBLeicestershire Partnership NHS Trust · GBNorthamptonshire Healthcare NHS Foundation Trust · GBUniversity of Birmingham · GBUniversity of Bonn · DEUniversity of Nottingham · GBWellcome Centre for Human Neuroimaging · GB

Funding

Medical Research Council MC_PC_14105Medical Research Council MR/P001408/1
6 · The paper itself

Abstract

It is unclear whether early psychosis in the context of cannabis use is different from psychosis without cannabis. We investigated this issue by examining whether abnormalities in oculomotor control differ between patients with psychosis with and without a history of cannabis use. We studied four groups: patients in the early phase of psychosis with a history of cannabis use (EPC; n = 28); patients in the early phase of psychosis without (EPNC; n = 25); controls with a history of cannabis use (HCC; n = 16); and controls without (HCNC; n = 22). We studied smooth pursuit eye movements using a stimulus with sinusoidal waveform at three target frequencies (0.2, 0.4 and 0.6 Hz). Participants also performed 40 antisaccade trials. There were no differences between the EPC and EPNC groups in diagnosis, symptom severity or level of functioning. We found evidence for a cannabis effect (χ

Identifiers

PMID33980870
PMCPMC8115050
OpenAlexW3161645846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.